Propylene glycol 40% / Clobetasol 0.05% ointment 25% / Coal tar solution 5% in Generic Unguentum M cream
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
MHRA licensed products
View all licensed products for Propylene glycol + Clobetasol + Coal tar on the MHRA register
Propylene glycol 40% / Clobetasol 0.05% ointment 25% / Coal tar solution 5% in Unguentum M cream
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 7 studies.
1988–2024
Showing all 7 studies, sorted by most relevant.
D. Asiedu, Clara Afia Amoah Dankwa
American Journal of Innovation in Science and Engineering, 2024
Cumene is a colorless, volatile liquid with a gasoline-like odor. It’s also known as isopropylbenzene, 2-phenylpropane, or (1-methylethyl) benzene. It’s a natural component of coal tar and crude oil, and it can also be employed in gasoline as a blending component. Cumene hydroperoxide is produced by oxidizing cumene with benzene and propylene in the presence of air. As a result, the cumene hydroperoxide is changed to cumyl alcohol, which is then transformed to propylene without the use of oxygen. Propylene oxide is an organic compound produced through various methods such as the cumene process and the hydroperoxide process. The cumene method is preferred due to its low by-product production and high market value of co-products. The reactive distillation process is a feasible method for producing propylene oxide with high purity and reduced costs. Future work includes optimizing processes, developing new catalysts, and improving efficiency. Propylene oxide has practical applications in the production of polyurethane foams, coatings, adhesives, polyether polyols, and propylene glycols.
Abstract licence: CC BY
Leon Kircik MD, Ryan Hartung PhD, Garrett Campbell, et al.
SKIN The Journal of Cutaneous Medicine, 2023
Definitions, 2020
Ope n Pe e r Re v ie w on Qe ios
Abstract licence: CC BY
Agarwal, Anshu, Deexith, Yeluri V. R. L. M., Jain, Devendra, et al.
'Medip Academy', 2022
International Journal of Toxicology, 2001
- Consumer Product Safety
- Toxicity Tests
- Cosmetics
W. R. Brown, T. Rogoziński, C. Ramsay
Clinical and Experimental Dermatology, 1988
- Ultraviolet Therapy
- Anthralin
- Cell Division
ATSDR's Toxicological Profiles, 2002
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.